Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges SI Q1 2026 Earnings Narrowed Loss Surpasses Expectations Yet Stock Declines National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Edges Higher Amid Limited Disclosures CLNN Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Neurological Pipeline AIXC Q3 2023 Earnings Significant EPS Beat Despite Net Loss DTE Energy Q1 2026 Earnings EPS Misses Consensus by 387 as Shares Edge Higher